• 1. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 2. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Aminopyridines and derivatives

Professional Introduction to 4,6-Dimethoxy-2-pyridinamine (CAS No. 914348-23-5)

4,6-Dimethoxy-2-pyridinamine, a compound with the chemical identifier CAS No. 914348-23-5, represents a significant area of interest in the field of pharmaceutical chemistry and medicinal biology. This heterocyclic amine derivative has garnered attention due to its unique structural properties and potential applications in drug development. The presence of methoxy groups at the 4th and 6th positions of the pyridine ring enhances its reactivity and makes it a valuable scaffold for synthesizing bioactive molecules.

The compound's molecular structure, characterized by a pyridine core substituted with two methoxy groups and an amine functional group at the 2-position, contributes to its versatility in chemical modifications. Such structural features are often exploited in medicinal chemistry to optimize pharmacokinetic profiles, enhance binding affinity to biological targets, and improve overall therapeutic efficacy. The 4,6-dimethoxy-2-pyridinamine moiety has been explored in various contexts, including the design of novel inhibitors and modulators for enzymes and receptors involved in critical biological pathways.

Recent advancements in computational chemistry and molecular modeling have facilitated a deeper understanding of the interactions between 4,6-dimethoxy-2-pyridinamine derivatives and biological targets. These studies have highlighted the compound's potential as a lead molecule for developing treatments against neurological disorders, inflammatory conditions, and metabolic diseases. The methoxy groups not only stabilize the molecule but also provide sites for further functionalization, enabling the creation of libraries of compounds with tailored properties.

In the realm of drug discovery, the synthesis of analogs of 4,6-dimethoxy-2-pyridinamine has been a focal point for research teams aiming to identify more potent and selective therapeutic agents. Techniques such as high-throughput screening (HTS) and structure-activity relationship (SAR) studies have been employed to evaluate the biological activity of various derivatives. Preliminary findings suggest that modifications at the amine group and the methoxy substituents can significantly alter the pharmacological profile of these compounds.

The role of 4,6-dimethoxy-2-pyridinamine in medicinal chemistry extends beyond its use as a standalone therapeutic agent. It serves as a key intermediate in the synthesis of more complex molecules designed to interact with specific biological targets. For instance, researchers have leveraged this scaffold to develop kinase inhibitors, which are crucial in treating cancers and inflammatory diseases. The ability to fine-tune the electronic properties of the pyridine ring through strategic substitutions allows for precise control over binding interactions.

The growing interest in 4,6-dimethoxy-2-pyridinamine is also driven by its potential in addressing emerging challenges in healthcare. As resistance to existing drugs becomes more prevalent, there is an urgent need for novel therapeutic strategies. The compound's unique chemical characteristics make it an attractive candidate for developing next-generation treatments that can overcome current limitations. Collaborative efforts between academic institutions and pharmaceutical companies are underway to explore its full potential.

From a synthetic chemistry perspective, 4,6-dimethoxy-2-pyridinamine offers opportunities for innovation in method development. The integration of green chemistry principles into its synthesis has led to more sustainable and environmentally friendly approaches. These advancements not only reduce waste but also improve yields, making large-scale production more feasible. Such developments align with global efforts to promote sustainable practices across all stages of drug development.

The future directions for research on 4,6-dimethoxy-2-pyridinamine are multifaceted. Ongoing studies aim to elucidate its mechanism of action in greater detail and identify new therapeutic applications. Additionally, exploring its interactions with other molecules may uncover synergistic effects that could enhance treatment outcomes. The compound's versatility ensures that it remains a relevant subject for both fundamental research and applied drug discovery initiatives.

In conclusion, 4,6-dimethoxy-2-pyridinamine (CAS No. 914348-23-5) stands as a testament to the ongoing innovation in pharmaceutical chemistry. Its unique structural features and potential applications make it a valuable asset in the quest for novel therapeutics. As research continues to uncover new insights into its properties and applications, this compound is poised to play an increasingly significant role in addressing global health challenges.

• 256642-28-1(2-Amino-4-6-dimethoxypyridine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)